Japan women health diagnostics market is growing at a CAGR of approximately 9.0% during the forecast period. According to the Ministry of Health, Labor and Welfare of Japan, cancer is an urgent public health challenge in Japan, especially for women. Over 340 thousand new cases are reported every year with female breast cancer being among the most common with 65 thousand new incidences. Since the rate of breast cancer cases has been increasing and with that a growing rate of mortality associated with the disease, there is a need for early detection and treatment. Both the younger and older generations of women in Japan are faced directly with this disease. Thus, the Japan women health diagnostic market is expected to increase.
Visit for Global Women Health Diagnostics Market Report at: https://www.omrglobal.com/industry-reports/womens-health-diagnostics-market-size
In the US and Europe, the most common age of diagnosis is for women around 60 years, though in Japan and in other Asian countries, there is a higher incidence of women being diagnosed in their 40’s. Rising women cancer cases and incidence in Japan increases the diagnosis of such kind of cancer to cure the same before it took the life of the patient. To overcome such issues, the Japanese government took a bold step forward in the field of global health by creating a public-private partnership called the Global Health Innovative Technology (GHIT) Fund to fund R&D for neglected tropical diseases (NTDs), diseases are not addressed by typical market mechanisms leaving nearly half of the world’s population with or at risk of a life-impacting health condition. The GHIT Fund’s current focus areas include visceral leishmaniasis, malaria, TB and Chagas disease and many other diseases, which directly contribute to the Japan women health diagnostics market.
The overall population of Japan in the year 2017 was around 124 million and the population of females was 4 million more than males. The total population of women is more than men in Japan, this increases the rising health care services for women. This directly augments the Japan women health diagnostics market in the forecast period.
Research Methodology
The market study of the Japan Women Health Diagnostics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
1. Japan Women Health Diagnostics Market Research and Analysis by Application
2. Japan Women Health Diagnostics Market Research and Analysis by End-user
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Japan Women Health Diagnostics Market by Applications
5.1.1. Breast Cancer Testing
5.1.2. Cervical Cancer Testing
5.1.3. Pregnancy & Fertility Testing
5.1.4. Ovarian Cancer Testing
5.1.5. Infectious Disease Testing
5.1.6. Ultrasound Tests
5.1.7. Sexually Transmitted Disease Testing
5.1.8. Others (Osteoporosis Testing and Prenatal Genetic Testing)
5.2. Japan Women Health Diagnostics Market by End-User
5.2.1. Diagnostic and Imaging Centers
5.2.2. Hospitals and Clinics
5.2.3. Home Care
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Becton, Dickson and Co.
6.3. biomerieux SA
6.4. F. Hoffmann-La Roche Ltd.
6.5. Fujifilm Holdings Corp.
6.6. General Electric Co.
6.7. Hologic, Inc.
6.8. Koninklijke Philips N.V.
6.9. Luminex Corp.
6.10. QIAGEN N.V.
6.11. Siemens AG
6.12. Thermo Fisher Scientific Inc.
1. JAPAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
2. JAPAN WOMEN HEALTH DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
1. JAPAN WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
2. JAPAN WOMEN HEALTH DIAGNOSTICS MARKET SHARE BY END-USER, 2018 VS 2025 (%)